Form 4 for GKOS GLAUKOS Corp
Accepted 2023-07-18 00:00:00 ET · period of report 2023-07-14 · accession 0001415889-23-011251 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-18 | 2023-07-14 | GKOS | Gilliam Joseph E | Pres, COO | M - OptEx | $38.36 | +42.1K | 162.6K | +35% | +$1.62M |
| D | 2023-07-18 | 2023-07-14 | GKOS | Gilliam Joseph E | Pres, COO | S - Sale+OE | $78.34 | -42.1K | 120.5K | -26% | -$3.30M |
| DM | 2023-07-18 | 2023-07-14 | GKOS | Gilliam Joseph E | Pres, COO | M - OptEx | $0.00 | -39.6K | 117.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-14 | M | A | 19,599 | $41.69 | 140,083 | D | — | — | (F1) Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 2 | Common | Common Stock | 2023-07-14 | M | A | 10,000 | $30.92 | 150,083 | D | — | — | (F1) Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 3 | Common | Common Stock | 2023-07-14 | M | A | 10,000 | $39.10 | 160,083 | D | — | — | (F1) Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 4 | Common | Common Stock | 2023-07-14 | M | A | 2,500 | $39.10 | 162,583 | D | — | — | (F1) Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 5 | Common | Common Stock | 2023-07-14 | S | D | 42,099 | $78.34 | 120,484 | D | — | — | (F1) Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-07-14 | M | D | 10,000 | $0.00 | 40,466 | D | $39.10 · — to 2030-03-12 | 10,000 Common Stock | (F5) This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-07-14 | M | D | 10,000 | $0.00 | 18,437 | D | $30.92 · — to 2028-03-14 | 10,000 Common Stock | (F4) This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-07-14 | M | D | 19,599 | $0.00 | 117,044 | D | $41.69 · — to 2027-05-05 | 19,599 Common Stock | (F3) This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. |